Sight Total Assets from 2010 to 2025

SGHT Stock

USD 2.74 0.18 7.03%

Sight Sciences Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 141.5 M in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

191.6 M

Current Value

141.5 M

Quarterly Volatility

93 M

Credit Downgrade

Yuan Drop

Covid

Check Sight Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sight Sciences' main balance sheet or income statement drivers, such as Tax Provision of 74.8 K, Interest Income of 0.0 or Depreciation And Amortization of 858.2 K, as well as many indicators such as Price To Sales Ratio of 3.38, Dividend Yield of 0.0 or PTB Ratio of 1.97. Sight financial statements analysis is a perfect complement when working with Sight Sciences Valuation or Volatility modules.

Check out the analysis of Sight Sciences Correlation against competitors.

For more information on how to buy Sight Stock please use our How to Invest in Sight Sciences guide.

Latest Sight Sciences' Total Assets Growth Pattern

Below is the plot of the Total Assets of Sight Sciences over the last few years. Total assets refers to the total amount of Sight Sciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Sight Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Sight Sciences' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sight Sciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 166.65 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Sight Total Assets Regression Statistics

	Arithmetic Mean	73,087,667
	Geometric Mean	27,204,487
	Coefficient Of Variation	127.27
	Mean Deviation	78,446,417
	Median	8,094,000
	Standard Deviation	93,016,441
	Sample Variance	8652.1T
	Range	272.1M
	R-Value	0.77
	Mean Square Error	3728.7T
	R-Squared	0.60
	Significance	0.0004
	Slope	15,105,366
	Total Sum of Squares	129780.9T

Sight Total Assets History

	2025	141.5 M
	2024	191.6 M
	2023	166.7 M
	2022	213.1 M
	2021	280.2 M
	2020	72.8 M
	2019	30.7 M

Other Fundumenentals of Sight Sciences

Intangibles To Total Assets

Sight Sciences Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Property Plant Equipment	Long Term Debt	Short Term Debt	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Short Long Term Debt
Total Assets		0.93	0.92	-0.98	-0.85	0.74	0.88	0.12	0.97	1.0	0.94	1.0	0.94	0.74	0.91	0.53	-0.34	0.48	0.52	-0.34
Total Stockholder Equity	0.93		0.99	-0.94	-0.83	0.69	0.81	-0.2	0.98	0.94	0.93	0.94	0.93	0.61	0.77	0.61	-0.45	0.52	0.56	-0.45
Net Tangible Assets	0.92	0.99		-0.91	-0.88	0.62	0.84	-0.19	0.96	0.92	0.94	0.92	0.94	0.6	0.8	0.71	-0.53	0.61	0.65	-0.53
Net Debt	-0.98	-0.94	-0.91		0.76	-0.82	-0.77	-0.04	-0.96	-0.98	-0.88	-0.98	-0.88	-0.72	-0.82	-0.41	0.26	-0.33	-0.37	0.26
Retained Earnings	-0.85	-0.83	-0.88	0.76		-0.4	-0.96	-0.1	-0.83	-0.85	-0.92	-0.84	-0.92	-0.56	-0.9	-0.85	0.56	-0.68	-0.74	0.56
Accounts Payable	0.74	0.69	0.62	-0.82	-0.4		0.4	0.22	0.67	0.75	0.51	0.75	0.51	0.81	0.56	0.06	-0.24	0.12	0.12	-0.24
Net Receivables	0.88	0.81	0.84	-0.77	-0.96	0.4		0.11	0.86	0.87	0.95	0.87	0.95	0.55	0.9	0.74	-0.4	0.66	0.72	-0.4
Total Liab	0.12	-0.2	-0.19	-0.04	-0.1	0.22	0.11		-0.13	0.12	-0.07	0.11	-0.07	0.44	0.38	-0.08	-0.01	-0.05	-0.05	-0.01
Net Invested Capital	0.97	0.98	0.96	-0.96	-0.83	0.67	0.86	-0.13		0.97	0.96	0.97	0.96	0.62	0.81	0.54	-0.3	0.48	0.52	-0.3
Total Current Assets	1.0	0.94	0.92	-0.98	-0.85	0.75	0.87	0.12	0.97		0.94	1.0	0.94	0.74	0.91	0.53	-0.33	0.47	0.52	-0.33
Capital Stock	0.94	0.93	0.94	-0.88	-0.92	0.51	0.95	-0.07	0.96	0.94		0.94	1.0	0.58	0.87	0.69	-0.38	0.62	0.67	-0.38
Net Working Capital	1.0	0.94	0.92	-0.98	-0.84	0.75	0.87	0.11	0.97	1.0	0.94		0.94	0.74	0.9	0.52	-0.33	0.47	0.51	-0.33
Common Stock	0.94	0.93	0.94	-0.88	-0.92	0.51	0.95	-0.07	0.96	0.94	1.0	0.94		0.58	0.87	0.69	-0.38	0.62	0.67	-0.38
Property Plant Equipment	0.74	0.61	0.6	-0.72	-0.56	0.81	0.55	0.44	0.62	0.74	0.58	0.74	0.58		0.66	0.33	-0.34	0.32	0.32	-0.34
Long Term Debt	0.91	0.77	0.8	-0.82	-0.9	0.56	0.9	0.38	0.81	0.91	0.87	0.9	0.87	0.66		0.65	-0.46	0.6	0.64	-0.46
Short Term Debt	0.53	0.61	0.71	-0.41	-0.85	0.06	0.74	-0.08	0.54	0.53	0.69	0.52	0.69	0.33	0.65		-0.8	0.86	0.89	-0.8
Deferred Long Term Liab	-0.34	-0.45	-0.53	0.26	0.56	-0.24	-0.4	-0.01	-0.3	-0.33	-0.38	-0.33	-0.38	-0.34	-0.46	-0.8		-0.83	-0.81	1.0
Long Term Debt Total	0.48	0.52	0.61	-0.33	-0.68	0.12	0.66	-0.05	0.48	0.47	0.62	0.47	0.62	0.32	0.6	0.86	-0.83		1.0	-0.83
Capital Surpluse	0.52	0.56	0.65	-0.37	-0.74	0.12	0.72	-0.05	0.52	0.52	0.67	0.51	0.67	0.32	0.64	0.89	-0.81	1.0		-0.81
Short Long Term Debt	-0.34	-0.45	-0.53	0.26	0.56	-0.24	-0.4	-0.01	-0.3	-0.33	-0.38	-0.33	-0.38	-0.34	-0.46	-0.8	1.0	-0.83	-0.81

Click cells to compare fundamentals

About Sight Sciences Financial Statements

Sight Sciences shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Sight Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in Sight Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Sight Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	191.6 M	141.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sight Stock Analysis

When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC